KLC1 and Alzheimer disease: Among these 95 genes, only GLS, KLC1 and NDRG1 were significantly up-regulated in the AD brain (Fig. 2B) and only GLS had available gene knockdown profiles in the CMap database, which could be used for the drug repositioning analysis.